PRESS RELEASE published on 05/13/2026 at 18:00, 4 months 4 days ago Strong momentum for the first nine months of the financial year: up 7.2% on an organic basis Groupe Bastide reports 5.0% revenue growth in Q3 2025-2026, driven by home healthcare services. Targets for 2025-2026 confirmed, focusing on operational improvements Operational Improvements Revenue Growth Groupe Bastide Home Healthcare Services 2025-2026 Targets
BRIEF published on 05/12/2026 at 18:35, 4 months 5 days ago Bastide shares and voting rights as of April 30, 2026 Voting Rights Ordinary Shares Preference Shares AMF Regulation Bastide Shares
BRIEF published on 04/02/2026 at 18:05, 5 months 15 days ago Status of shares and voting rights of Bastide Le Confort Médical as of March 31, 2026 Ordinary Shares Exercisable Voting Rights Preference Shares Theoretical Voting Rights BASTIDE MEDICAL COMFORT
BRIEF published on 03/31/2026 at 18:05, 5 months 17 days ago Bastide's half-yearly financial report is now available Revenue Financial Report Publication Bastide Group Fiscal Year 2025-2026
BRIEF published on 03/25/2026 at 08:05, 5 months 23 days ago Groupe Bastide transfers its liquidity contract to Portzamparc Euronext Paris Liquidity Contract PORTZAMPARC BNP Paribas Bastide Group
BRIEF published on 03/18/2026 at 18:50, 5 months 30 days ago Groupe Bastide Reports Solid 2025-2026 Half-Year Results Operating Profit Cash Flow Half-year Results Groupe Bastide Financial Leverage
PRESS RELEASE published on 03/18/2026 at 18:45, 5 months 30 days ago 2025-2026 half-year results Groupe Bastide reports strong half-yearly results for 2025-2026 with 9.0% operating margin, 12.5% profit increase, and improved financial leverage. Revenue grows by 8.0% organically Revenue Growth Operating Margin Groupe Bastide Financial Leverage Half-yearly Results
BRIEF published on 03/18/2026 at 18:35, 5 months 30 days ago Solid half-year results for the Bastide Group Free Cash Flow Half-year Results Bastide Group Financial Leverage Home Healthcare
BRIEF published on 03/04/2026 at 18:10, 6 months 13 days ago BASTIDE: Capital Composition and Voting Rights as of February 28, 2026 AMF Transparency Shares And Voting Rights Social Capital BASTIDE MEDICAL COMFORT
BRIEF published on 02/12/2026 at 18:35, 7 months 5 days ago Bastide's Robust First-Half Growth in 2025-2026 Bastide Growth Homecare Revenue Respiratory Segment Diabetes Growth 2025-2026 Forecast
Published on 09/17/2026 at 15:55, 4 hours 5 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 4 hours 35 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 15:00, 5 hours ago Norsemont Hits 41 Meters of 4.59 g/t Gold as Phase 3 Drilling Continues to Expand the Choquelimpie System
Published on 09/17/2026 at 15:00, 5 hours ago ECC Ventures 4 Announces Termination of Agreement With Cambria Gold Mines Inc.
Published on 09/17/2026 at 14:50, 5 hours 10 minutes ago Caldwell Strengthens Human Resources Practice with Addition of Ali Palmer as Partner
Published on 09/17/2026 at 19:00, 59 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 1 hour 1 minute ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 1 hour 34 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 1 hour 49 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 2 hours 13 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 2 hours 20 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 2 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 13 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
